ANKHD1 (ankyrin repeat and KH domain containing 1)
2015-03-01 Joao Agostinho Machado-Neto, PhD , Fabiola Traina   AffiliationIdentity
Abstract
ANKHD1 is differentially expressed in human cancers, and potentially regulates multiple cellular functions and participates as a scaffold for protein-protein interactions through its ankyrin-repeat domains. Recently, studies have indicated that ANKHD1 is involved in the regulation of important biological process that participate in the malignant phenotype, including cell cycle progression, proliferation, clonogenicity and migration. The present review on ANKHD1 contains data on DNA\/RNA, protein encoded and where the gene is implicated.
DNA/RNA
Description
Proteins

Description
Expression

Localisation

Function

Homology
Mutations
Somatic
Implicated in
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 23142581 | 2012 | ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells. | Dhyani A et al |
| 25483783 | 2015 | ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth. | Dhyani A et al |
| 19619540 | 2009 | Ankrd17, an ubiquitously expressed ankyrin factor, is essential for the vascular integrity during embryogenesis. | Hou SC et al |
| 25653910 | 2015 | Tandem-repeat protein domains across the tree of life. | Jernigan KK et al |
| 16094372 | 2005 | Identification of JAK/STAT signalling components by genome-wide RNA interference. | Müller P et al |
| 25523139 | 2015 | ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. | Machado-Neto JA et al |
| 16098192 | 2005 | Molecular and functional characterization of a novel splice variant of ANKHD1 that lacks the KH domain and its role in cell survival and apoptosis. | Miles MC et al |
| 23333314 | 2013 | Mask is required for the activity of the Hippo pathway effector Yki/YAP. | Sansores-Garcia L et al |
| 23333315 | 2013 | Mask proteins are cofactors of Yorkie/YAP in the Hippo pathway. | Sidor CM et al |
| 11782402 | 2002 | MASK, a large ankyrin repeat and KH domain-containing protein involved in Drosophila receptor tyrosine kinase signaling. | Smith RK et al |
| 16956752 | 2006 | ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells. | Traina F et al |
Other Information
Locus ID:
NCBI: 54882
MIM: 610500
HGNC: 24714
Ensembl: ENSG00000131503
Variants:
dbSNP: 54882
ClinVar: 54882
TCGA: ENSG00000131503
COSMIC: ANKHD1
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37629022 | 2023 | Evaluating the Molecular Properties and Function of ANKHD1, and Its Role in Cancer. | 1 |
| 37629022 | 2023 | Evaluating the Molecular Properties and Function of ANKHD1, and Its Role in Cancer. | 1 |
| 35110552 | 2022 | The feedback loop of ANKHD1/lncRNA MALAT1/YAP1 strengthens the radioresistance of CRC by activating YAP1/AKT signaling. | 11 |
| 35110552 | 2022 | The feedback loop of ANKHD1/lncRNA MALAT1/YAP1 strengthens the radioresistance of CRC by activating YAP1/AKT signaling. | 11 |
| 32319569 | 2020 | ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. | 6 |
| 32562952 | 2020 | ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells. | 3 |
| 32635985 | 2020 | Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processes. | 5 |
| 32319569 | 2020 | ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. | 6 |
| 32562952 | 2020 | ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells. | 3 |
| 32635985 | 2020 | Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processes. | 5 |
| 30646949 | 2019 | ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma. | 24 |
| 30646949 | 2019 | ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma. | 24 |
| 29695508 | 2018 | Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs. | 16 |
| 29695508 | 2018 | Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs. | 16 |
| 25483783 | 2015 | ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth. | 15 |
Citation
Joao Agostinho Machado-Neto, PhD ; Fabiola Traina
ANKHD1 (ankyrin repeat and KH domain containing 1)
Atlas Genet Cytogenet Oncol Haematol. 2015-03-01
Online version: http://atlasgeneticsoncology.org/gene/46476/ankhd1-(ankyrin-repeat-and-kh-domain-containing-1)
